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Cell migrationThe tripartite motif containing (TRIM) proteins are a large family of proteins that have been implicated in many
biological processes including cell differentiation, apoptosis, transcriptional regulation, and signaling pathways.
Here, we show that TRIM15 co-localized to focal adhesions through homo-dimerization and signiﬁcantly sup-
pressed cell migration. Domain mapping analysis indicated that B-box2 and PRY domains were essential for
TRIM15 localization to focal adhesions and inhibition of cell migration. Our protein-protein interaction screen
of TRIM15 with the integrin adhesome identiﬁed several TRIM15 interacting proteins including coronin 1B,
cortactin, ﬁlamin binding LIM protein1, and vasodilator-stimulated phosphoprotein, which are involved in
actin cytoskeleton dynamics. TRIM15 expression was tissue-restricted and downregulated in colon cancer.
Level of TRIM15 expression was associated with colon cancer cell migration, as well as both in vitro and in vivo
tumor growth. These data provide novel insights into the role of TRIM15 as an additional component of the
integrin adhesome, regulating cell migration, and suggest that TRIM15 may function as a tumor suppressor of
colon cancer.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
The tripartite motif containing (TRIM) protein family is character-
ized by the presence of three distinct motifs in the N-terminal region:
a really interesting new gene (RING) domain, and one or two B-box do-
mains, and a coiled-coil domain [1]. Given the high conservation of the
order of these domains in the TRIM protein family members, the TRIM
proteins are also known as RBCC proteins. Humans have more than 60
TRIM proteins, which are classiﬁed into 11 subgroups based on the do-
main composition of the C-terminal region [2–4]. Ten different types of
C-terminal domains exist in TRIM familymembers, namely the COS box,
ﬁbronectin type 3, PRY/SPRY, plant homeodomain, bromodomain, NHL,ctin; DAPI, 4′,6-diamidino-2-
; ECM,cell-extracellularmatrix;
IM protein 1; FBS, fetal bovine
ne s-transferase; RING, really
; VASP, vasodilator-stimulated
ical Science, CHA University,
o, 463-400, Republic of Korea.ﬁlamin-type immunoglobulin, ADP ribosylation factor-like, MATH, and
transmembrane domains. The most common C-terminal domain of
TRIM proteins is the PRY/SPRY domain. Among the identiﬁed TRIM pro-
teins, 34members of the TRIM protein family contain a SPRY domain or
a fusion of a PRY and SPRY domain [3,4]. Although many TRIM proteins
play well-known roles in innate immunity by interfering with the viral
replication cycle and regulating immune signaling pathways, TRIM pro-
teins have also been implicated in diverse cellular processes, including
cell differentiation, apoptosis, and transcriptional regulation [3–6].
TRIM15, also known as RNF93 or ZNFB7, contains a PRY/SPRY do-
main in the C-terminal region. A recent study proposed TRIM15 as a can-
didate gene for diagnosing gastric cancer, because DNA methylation
levels of TRIM15 were higher in gastric cancer tissues than in normal
gastric tissues [7]. TRIM15mRNAexpressionwas downregulated in gas-
tric cancer, suggesting that lower TRIM15 expressionmay be involved in
development of gastric cancer. In other studies, TRIM15was reported as
a restriction factor for the murine leukemia virus and human immuno-
deﬁciency virus 1 by interacting with the retroviral Gag protein and
inhibiting viral release [6]. Despite these interesting ﬁndings, little is
known about the functional roles and tissue expression patterns of
TRIM15. In addition, TRIM15 may be associated with other disease
states. In this study, we focused on deciphering the molecular and
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matrix (ECM) adhesion component that interacted with several regula-
tors involved in actin dynamics, ultimately suppressing cell migration.
Furthermore, we demonstrated that TRIM15 was highly expressed in
normal human colon tissues, and its expression was diminished in
colon adenocarcinoma. Restoring expression of TRIM15 in colon cancer
cells reduced tumor growth in mice, suggesting an important role for
TRIM15 in suppression of cellular transformation.
2. Materials and methods
2.1. Plasmids
The pDONR223 vector that encoded TRIM15 was obtained from the
human ORFeome v3.1 (Open Biosystems, Lafayette, CO, USA). Using
Gateway recombination (Invitrogen, Carlsbad, CA, USA), the TRIM15
was transferred into destination vectors to tag TRIM15 with N-terminal
half yellow ﬂuorescence protein (YFPn; pBabe-CMV-TRIM15-YFPn-
neo), C-terminal half yellow ﬂuorescence protein (YFPc; pCl-CMV-
TRIM15-YFPc-puro), glutathione S-transferase (GST; pDEST27-TRIM15),
or FLAG (pCl-CMV-2xFLAG-TRIM15-puro) [8]. The DNA fragments
encoding TRIM15 deletion mutants were generated by PCR, cloned into
the pENTR/D-TOPO vector (Invitrogen), and transferred into pCl-CMV-
2xFLAG-DEST-puro vector using Gateway recombination.
2.2. Cell cultures
U2OS and 293T cells were cultured in high glucose Dulbecco's
Modiﬁed Eagle's Medium (DMEM), HCT116, HT-29, and LOVO cells
were cultured in RPMI medium, and CCD18Co cells were maintained
in Minimum Essential Medium. The media for all the cells were supple-
mented with 10% fetal bovine serum (FBS), 100 units/ml penicillin,
and 100 μg/ml streptomycin. To establish cells that stably expressed
vector or FLAG-TRIM15, empty pCl-CMV-2xFLAG-puro vector [8]
or the pCl-CMV-2xFLAG-TRIM15-puro vector was co-transfected
with pCl-Ampho vector into 293T cells. After 2 days, U2OS, HCT116, or
HT-29 cells were infected with the collected retroviral supernatants
from the 293T cells and treated with 1 μg/ml puromycin for more
than 10 days. To stimulate cells with epidermal growth factor (EGF),
HCT116 cells stably expressing vector or FLAG-TRIM15 were serum-
starved for 24 h and treated with 50 ng/ml of human recombinant
EGF (Sigma-Aldrich, St. Louis, MO, USA) for the indicated time. For
knockdown experiments, TRIM15 and CTTN siRNAs were obtained
from Bioneer (Seoul, Korea) and transfected into LOVO or U2OS cells
using Lipofectamine RNAiMax (Invitrogen). The sequence of CTTN
siRNA was 5′-GGAACUUGAAACAGGACCA-3′. The sequences for the
TRIM15 siRNAs were the following: siRNA1 (5′-AGCAGGCAGAGACU
CCCAU-3′) and siRNA2 (5′-CCCAAUCCUCGGGCAAGAU-3′).
2.3. Antibodies
The following antibodies were used for the immunoblotting ex-
periments: anti-FLAG M2 (Sigma-Aldrich), anti-GST (GE Healthcare,
Buckinghamshire, UK), anti-phospho-cortactin (Tyr421), anti-cortactin
(Cell Signaling Technology Inc., Danvers, MA, USA), and anti-β-actin
(Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA) antibodies. A rab-
bit polyclonal antibody against the TRIM15was generated by Abfrontier
(Seoul, Korea) by immunizing rabbits with the keyhole-limpet
hemocyanin-conjugated synthetic peptides C-EQQIWKERDEYITK
and C-SEDRKSVRYTRQKKS that correspond to the amino acid residues
195-208 and 310-324 of the human TRIM15, respectively. The anti-
TRIM15 antibody was afﬁnity-puriﬁed, and the speciﬁcity of the anti-
body was validated. Anti-TRIM15 antibody was applicable to Western
blotting and immunohistochemistry, but not to immunoprecipitation
(Fig. S1).2.4. Immunoﬂuorescence
Cells were cultured on 12 mm glass coverslips and ﬁxed with
3% paraformaldehyde/2% sucrose in phosphate buffered saline for
10 minute (min) at room temperature. The cells permeabilized with
Triton X-100 buffer (0.5% Triton X-100, 20 mM Hepes-KOH, pH7.9,
50 mM NaCl, 3 mM MgCl2, and 300 mM sucrose) were incubated
with the rabbit anti-FLAG (Sigma-Aldrich) and mouse anti-vinculin
(Sigma-Aldrich) antibodies for 1 hour (h) at room temperature. After
washing, the cells were incubated with an Alexa Fluor 488 conjugated
anti-mouse antibody (Invitrogen), a Rhodamine Red-X conjugated
anti-rabbit antibody (Invitrogen), and an Alexa Fluor 633 conjugated
phalloidin (Invitrogen) for 1 h at room temperature. The cells were
mounted with the ProLong antifade reagent (Invitrogen) containing
4′,6-diamidino-2-phenylindole (DAPI). The images were captured with
an inverted LSM700 confocal microscope (Carl Zeiss, Inc., Oberkochen,
Germany).
2.5. Transwell migration assay
Migration assay was performed according to a previously described
method [9]. Brieﬂy, bottom surfaces of ﬁlters with an 8 μmpore diame-
ter were coated with 10 μg/ml ﬁbronectin. Cells (2 × 105) were
suspended in 100 μl of DMEM containing 1 mg/ml of bovine serum
albumin and added to upper chamber of a transwell (Corning Costar,
Corning, NY, USA). The lower compartments of the transwell chambers
wereﬁlledwith 600 μl of DMEMcontaining 10% FBS. After an incubation
at 37 °C, the migrated cells were ﬁxed and stained with hematoxylin.
Incubation time was optimized for each cell types (U2OS cells for 7 h,
HCT116 cells for 1 day, HT-29 and LOVO cells for 2 days). After removing
cells that did not migrate, migration was quantiﬁed by counting
the cells that migrated through pores. Eight independent ﬁelds were
counted under a microscope (200× magniﬁcation) (Carl Zeiss). The re-
sults were expressed as a percentage of control cells.
2.6. Fluorescent protein complementation assay
Fluorescent protein complementation assay was performed as pre-
viously described [8]. Brieﬂy, the pBabe-CMV-TRIM15-YFPn-neo and
pCl-Ampho vectors were co-transfected into 293T cells for retrovirus
production and subsequent infection of HTC75 cells. The bait cells stably
expressing TRIM15 conjugated with YFPn were selected by treatment
with 300 μg/ml G418. To screen the TRIM15 binding proteins with
integrin adhesome proteins (www.adhesome.org) [10], 127 of avail-
able integrin adhesome proteins were selected from our previous
high-throughput protein complementation array screen system and
reconstituted into 96 well plates (Fig. S2). Individual clone of YFPc-
adhesome proteins with pCl-Ampho were then co-transfected into
293T cells to generate retroviruses. Retroviral supernatantwas collected
at 48 h post-transfection. The TRIM15 bait cells were seeded onto 24-
well plates and infected with the retrovirus encoding a YFPc-tagged
integrin adhesome protein. At 2 days following the infection, cells
were selected with 1 μg/ml of puromycin for 10 days. Cells were then
harvested for ﬂow cytometry analysis using the LSRII ﬂow cytometer
(BD Biosciences, San Jose, CA, USA). According to data of our previous
complementation assay, we considered the nonspeciﬁc signals for com-
plementation assay by 6.37 ± 3.66% YFP positives [8]. The identiﬁed
proteins were analyzed by the Ingenuity Pathway Analysis program
(Redwood City, CA, USA) to determine network and function.
2.7. Co-precipitation and immunoblotting
The indicated geneswere cloned into either pDEST27 (Invitrogen) to
tag with GST or pCl-CMV-2xFLAG-DEST-puro for FLAG. The indicated
plasmids were co-transfected into 293T cells using Lipofectamine
2000 (Invitrogen). The transfected cells were harvested 2 days after
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NaCl, 10% glycerol, 1% Triton X-100, 2 mM EDTA). The pre-cleared cell
lysateswere incubatedwith glutathione agarose beads (BDBiosciences)
or anti-FLAG M2 agarose beads (Sigma-Aldrich) for 1 h at 4 °C. After
washing, the bound proteinswere analyzed by SDS-PAGE and immuno-
blotting. The immunoreactive bands were detected by chemilumines-
cence using the ECL reagents (GE Healthcare).
2.8. Analysis of TRIM15 mRNA
Total RNAs from cell lines were isolated by using an RNeasy Plus kit
(Qiagen Inc., Valencia, CA, USA) and converted to cDNA using iScript
cDNA Synthesis kit (Bio-Rad Laboratories, Hercules, CA, USA). Human
MTC panel I/II and the human colon matched cDNA pair panel were ob-
tained from Clontech (Mountain View, CA, USA). For the conventional
RT-PCR, TRIM15 PCR products were generated by PCR ampliﬁcation
from2.5 μl of cDNA template in a total volume of 25 μl using the Cheetah
Hot-Start Taq polymerase (Biotium, Inc. Hayward, CA, USA). The
primers used for the conventional RT-PCR were as follows: TRIM15
(5′-GGCCATTCAGCCCTACCGGG-3′ and 5′-GACTCTGACATCTTGTAGAA
GCTC-3′) and β-actin (5′-ATCTGGCACCACACCTTCTACAATGAGCTGCG-
3′ and 5′-CGTCATACTCCTGCTTGCTGATCCACATCTGC-3′). Quantitative
real-time PCR was performed using the SYBR Green reagent (Roche ap-
plied Science, Germany) and a LightCycler 480 System (Roche applied
Science) according to the manufacturer's instructions. The primers
used for the quantitative real-time PCR were as follows: TRIM15 (5′-
GCCCGCTGGGAGAAACTTAC-3′ and 5′-GGCATCGTTCTCGCAGAAG-3′)
and 18S rRNA (5′-CGAACGTCTGCCCTATCAACTT-3′ and 5′-ACCCGTGG
TCACCATGGTA-3′). The PCR reactions were performed in triplicate,
and the relative expression level of TRIM15 mRNA was normalized to
the 18S rRNA level using the comparative CT (ΔΔCT) method [11].
2.9. Immunohistochemistry
A tissue microarray (A303 I) composed of 32 normal and colon can-
cer tissues was purchased from ISU ABXIS Co., LTD (Seoul, Korea). The
tissuemicroarraywas rehydrated and processed in 10mMcitrate buffer
(pH6.0) for antigen retrieval. After blocking for 1 h at room temperature
with a blocking solution containing 5% skimmilk and 1% BSA, the tissues
were incubated with the anti-TRIM15 antibody (1:500) at 4 °C over-
night. The tissues were further processed with an avidin-biotin-
horseradish peroxidase complex (Vector Labs, Burlingame, CA, USA).
The peroxidase signalswere developedwith a 0.01% 3,3′-diaminobenzi-
dine solution (Vector Labs) according to the manufacturer's protocol
and counterstained with hematoxylin. The images were obtained with
an Axio microscope (Carl Zeiss)
2.10. Soft agar assay for colony formation
HCT116 and HT-29 cells stably expressing vector or FLAG-TRIM15
were suspended in 0.3% agarose in complete medium and plated onto
a layer of 0.6% agarose in complete medium in 6-well plates (1 × 104
cells/well). Colonies were allowed to grow for 25–30 days in the growth
medium. The colonies were stained with 3-[4,5-dimethyl-2-thiazolyl]-
2,5-diphenyltetrazolium bromide and photographed. The number of
colonies was counted by blind observers.
2.11. Xenotransplantation assay
All animal experiments were approved by Institutional Animal Care
and Use Committee of National Cancer Center in Korea. HT-29 cells ex-
pressing vector control or FLAG-TRIM15 (3.5 × 106 cells/spot)were sub-
cutaneously injected into the left ﬂank region of 6 weeks old female
nudemice (n= 9/group). Tumor volumesweremeasured using caliper
and determined by a formula [volume= (length ×width2)/2] from day6 to day 22 following injection of cancer cells. The results were
expressed as mean tumor volumes with SD.
2.12. Statistical analysis
The data are presented as the mean ± SD, and statistical analysis
was performed using SPSS statistics package for Windows (Version
20.0, IBM Inc., Chicago, IL, USA). The statistical signiﬁcance of the com-
parisonswas evaluated by the Student's t-test for independent samples.
For all analyses, a p b 0.05 was considered to be statistically signiﬁcant.
3. Results
3.1. TRIM15 is localized to cell-ECM adhesions
Despite signiﬁcant sequence and structural similarity, the TRIM pro-
tein family members have a variety of different subcellular localizations
[1], which suggests that these proteins have diverse and unique func-
tional activities. To understand the molecular and cellular functions
of TRIM15, we examined subcellular localization of TRIM15 in living
cells using GFP. The majority of TRIM15-GFP was accumulated in
small streaks (Fig. 1A). To eliminate tagging effect of GFP on the speciﬁc
localization pattern of TRIM15, we generated stable cells that expressed
FLAG-tagged TRIM15 and stained the cells with an anti-FLAG antibody
and phalloidin. Confocal microscopy revealed that TRIM15 was clus-
tered at cell-ECM adhesion sites where focal complexes were formed
as well as focal adhesions where the actin stress ﬁbers were anchored
(Fig. 1B).
To conﬁrm that TRIM15 localized to focal complexes or focal adhe-
sions, the cells stably expressing FLAG-TRIM15 were stained with
the antibody that speciﬁcally recognized vinculin, a component of
focal complexes or focal adhesions. The results showed that TRIM15
completely co-localized with vinculin (Fig. 1C). Because vinculin is
also a component of cell-cell junctions [12], we tested whether
TRIM15 functions at cell-cell contacts in conﬂuent cells using co-
staining with an antibody against tight junction marker ZO-1. TRIM15
was not associated with cell-cell adhesion sites where a tight junction
is enriched (Fig. 1D). Taken together, the data indicated that TRIM15
is a component that links the membrane and cytoskeletons in sites of
cell-ECM adhesions.
3.2. TRIM15 homo-dimerizes through its coiled-coil domain
TRIM protein family members are known to homo-dimerize [1]. We
performed a ﬂuorescent protein complementation assay in live cells
to directly investigate whether TRIM15 homo-dimerized [8,13,14].
Homo-dimerization of TRIM15 was detected by the presence of YFP
ﬂuorescence using ﬂow cytometry (Fig. 2A). To conﬁrm the homo-
dimerization of TRIM15 biochemically, vectors encoding FLAG-tagged
and GST-tagged TRIM15 were co-transfected into 293T cells. Consistent
with the protein complementation assay, co-immunoprecipitation and
GST pull down assays demonstrated that TRIM15 was readily detected
as a homo-dimer (Fig. 2C).
To determine which domains are responsible for TRIM15 dimeriza-
tion, we generated FLAG-tagged TRIM15 deletion mutations that lacked
individual domains or a combination of domains (Fig. 2B). 293T cells
were co-transfected with GST-tagged TRIM15 and FLAG-tagged TRIM15
deletion mutants. A GST-pull down assay demonstrated that the coiled-
coil domain is required for the dimerization of TRIM15 (Fig. 2D).
3.3. The B-box2 and PRY domains are necessary for TRIM15 localization to
focal adhesions and TRIM15-induced inhibition of cell migration
To test which domains were involved in the subcellular localization
of the TRIM15, we generated stable cell lines expressing TRIM15 dele-
tion mutants. The ΔRING or ΔSPRY mutants were still recruited to the
Fig. 1. The subcellular localization of TRIM15. A) The localization of GFP-tagged TRIM15 was observed in live U2OS cells stably expressing TRIM15-GFP under a ﬂuorescent microscope.
Hoechst 33342 was used to stain the nuclei of the live cells. The scale bar indicates 10 μm. B) U2OS cells stably expressing FLAG-TRIM15 were stained with phalloidin and an anti-
FLAG antibody to detect F-actin and TRIM15, respectively. Regions i and ii are enlarged to show the localization of TRIM15 in the (i) focal complex and (ii) focal adhesion sites. The
scale bars indicate 5 μm. C) Subconﬂuent U2OS cells stably expressing FLAG-TRIM15 were stained with phalloidin, anti-FLAG, and anti-vinculin antibodies. The scale bars indicate
10 μm. D) Conﬂuent U2OS cells expressing FLAG-TRIM15 were stained with phalloidin, anti-FLAG and anti-ZO-1 antibodies. The scale bars indicate 10 μm. U2OS cells containing vector
were used as control. DAPI was used for nucleus staining.
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tion of the B-box2 or PRY domains, however, failed to localize to the
focal adhesion sites and were diffused throughout the cytoplasm and
nucleus with no disruption of vinculin localization to the focal adhesion
sites (Fig. 3A,B). Moreover, the disruption of the PRY region of TRIM15
led to the localization of TRIM15 with ﬁbrillar actin in the cytoplasm.
Together, these results suggest that the region of TRIM15 from B-box2
domain through the PRY domain plays an important role in localizing
TRIM15 to focal adhesion.Cell migration and adhesion are coordinated by a complex of pro-
teins that localize to sites of focal adhesion. To investigate whether
TRIM15 is involved in the regulation of cellularmigration,we compared
the motility of cells that stably expressed TRIM15 to a vector control
using the transwell migration assay. The results showed that TRIM15-
expressing cells migrated remarkably slower than the vector control
cells (Fig. 3C). Despite this difference, there was no change in cell adhe-
sion to the ECM between TRIM15 stable cells and control cells, assessed
by monitoring adhesion to laminin and ﬁbronectin (Fig. S3). To address
Fig. 2. The homo-dimerization of TRIM15 through its coiled-coil domain. A) A ﬂuorescent protein complementation assay was used to determine the level of TRIM15 dimerization.
A Venus YFP N-terminal fragment tagged TRIM15 (TRIM15-YFPn) was co-expressed with a YFP C-terminal fragment (YFPc) alone or a YFPc-tagged TRIM15 in U2OS cells. The per-
centage of YFP-positive cells was measured by ﬂow cytometry. B) A schematic representation of the deletion mutants of TRIM15 used in this study is shown. ΔRING, ΔRING/BB,
ΔRING/BB/CC, ΔSPRY, and ΔPRY/SPRY TRIM15 correspond to the amino acid (aa) 70-465, aa 122-465, aa 247-465, aa 1-377, and aa 1-240, respectively. C) A biochemical analysis
of the level of TRIM15 dimerization. 293T cells were co-transfected with plasmids encoding GST or GST-TRIM15 with or without FLAG-TRIM15. The FLAG-TRIM15
was immunoprecipitated using an anti-FLAG antibody, or GST-TRIM15 was precipitated using glutathione agarose beads. The level of TRIM15 dimerization was determined by im-
munoblotting with the anti-FLAG or anti-GST antibodies. D) TRIM15 protein without the coiled-coil domain does not interact with the full-length TRIM15 protein. 293T cells
were co-transfected with GST-TRIM15 and the indicated FLAG-TRIM15 deletion mutant. GST-TRIM15 was bound by glutathione agarose beads. The co-precipitated amounts
of the FLAG-TRIM15 mutants were visualized by immunoblotting with an anti-FLAG antibody. The same membrane was stripped and re-blotted with an anti-GST antibody. Input
contains 1% of the cell lysates.
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Fig. 3. Mapping critical domains for TRIM15 localization to focal adhesions and cell migration. A) U2OS cells stably expressing FLAG-tagged full length TRIM15 or one of the TRIM15
deletion mutants were ﬁxed and stained with phalloidin, as well as anti-FLAG and anti-vinculin antibodies. The TRIM15 mutants with a deleted B-box2 or PRY domain lost the local-
ization of TRIM15 to focal adhesions. DAPI was used for nuclei staining. The scale bars indicate 10 μm. B) A Western blot analysis of the protein levels of the wild-type or deletion
mutants of TRIM15 in stably transfected U2OS cells. C,D) TRIM15 inhibits cell migration, and B-Box2 and PRY domains are critical for this function. The migration of each stable
cell line through the transwells was determined by directly counting the cells that passed through the membrane. Representative photographs are shown in C. Quantitative results
(D) represent the relative percentage of migration compared to the migration of the U2OS cells stably expressing the vector alone (normalized to 100%). The experiments were per-
formed in triplicate. The mean percentage of migration was obtained from three independent experiments. *p b 0.05 versus vector control cells; #p b 0.05 versus wild type TRIM15
cells.
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tion, we examined the effects of the TRIM15 deletion mutants on cellu-
lar migration. Consistent with their loss of localizations to focal
adhesions, the TRIM15 ΔRING/BB and ΔPRY/SPRY mutants could not
signiﬁcantly inhibit cell migration, indicating that the localization
of TRIM15 to focal adhesion is important for the inhibition of cellular
migration (Fig. 3C,D).3.4. TRIM15 interacts with regulators of actin dynamics
Cell-ECM adhesions are mediated by integrin and composed of
multi-protein complexes that link the ECM to the actin cytoskeleton.
According to an in silico study, these adhesion complexes, known as
the integrin adhesome, are composed of 180 protein components [10].
Previously, we established a high-throughput arrayed screening system
based on protein complementation to systematically investigate
protein-protein interactions in live human cells [8]. We picked 127
vectors that encoded integrin adhesome proteins and attempted to
identify which of these interacted with TRIM15 using a ﬂuorescence
protein complementation assay (Fig. S2). We identiﬁed 25 potential
TRIM15-interacting proteins (Table S1). To conﬁrm these results, we
tagged the 25 proteins with a FLAG tag, co-expressed them individually
with GST-tagged TRIM15 in 293T cells, and performed GST pull down
assay. By this method, TRIM15 interacted with several adaptors or
scaffold proteins for actin cytoskeleton dynamics, including coronin 1B
(CORO1B), cortactin (CTTN), ﬁlamin binding LIM protein1 (FBLIM1),
and vasodilator-stimulated phosphoprotein (VASP) (Fig. 4A,B,C).
TRIM15 also associated with AKT1 and SRC, kinases that regulate
protein activity by phosphorylation, and NCK2 and CRK, SH2 and SH3-
containting adaptors that recruit several signaling molecules (Fig. S4).
CTTNplays a critical role in cellmotility by regulating actin dynamics.
To check whether TRIM15 can interact with native CTTN, we carried out
co-immunoprecipitation assay. Because our anti-TRIM15 antibody was
inefﬁcient to immunoprecipitate TRIM15 (Fig. S1), FLAG-TRIM15 in
U2OS cells stably expressing FLAG-TRIM15 was immunoprecipitated
using anti-FLAG antibody. As shown in Fig. 5A, a signiﬁcant binding
signal of native CTTN with FLAG-TRIM15 was observed. Examination
of the localization of TRIM15 and CTTN by immunoﬂuorescence showed
that TRIM15 and CTTN were co-localized to the leading edge of the cell
membrane where cell-ECM adhesions are abundant (Fig. 5B). Next, we
analyzed the effect of TRIM15 on CTTN tyrosine phosphorylation,
because the tyrosine phosphorylation status of CTTN correlates with de-
polymerization and destabilization of actin ﬁlaments, which allows
cell movement [15]. Since EGF is known to stimulate CTTN tyrosine
phosphorylation [16], cells were treated with EGF. As shown in Fig. 5C,
EGF stimulated the tyrosine phosphorylation of CTTN in control cells
in a rapid and sustained manner. However, we did not observe EGF-
induced CTTN phosphorylation in cells stably expressing TRIM15.
Next, we investigated the role of CTTN in TRIM15 localization to cell-
ECM adhesion sites and inhibition of cell motility by TRIM15. Knock-
down of CTTN by siRNA treatment did not alter TRIM15 localization to
focal adhesion, implying that the recruitment of TRIM15 to focal com-
plexes or focal adhesions was in CTTN-independent manner (Fig. S5).
The effect of CTTN on the cell motility was inﬂuenced by the level of
TRIM15. Knockdown of CTTN expression negatively regulated motility
of control U2OS cells that contained lower level of phosphorylated
CTTN in quiescent status, compared to U2OS cells stably expressing
TRIM15. Knockdown of CTTN in TRIM15-expressing cells did not de-
crease cell motility, whereas motility was slightly enhanced by CTTN
siRNA (Fig. 5D,E). These results were similar to the data demonstrating
that CTTN had dual function in regulating cell motility. Negative or
positive effect of CTTN on cell migration depended on its phosphoryla-
tion status [17]. Taken together, these results suggest that TRIM15
may inhibit cell migration by impairing signal-dependent phosphoryla-
tion of CTTN.3.5. Expression of TRIM15 in normal human tissues
We wanted to investigate the expression pattern of TRIM15 in nor-
mal tissues. TRIM15 mRNA was highly expressed in the kidney and
colon tissues and slightly expressed in the liver and small intestine.
TRIM15 mRNA was not detectable or very minimally expressed in the
heart, brain, placenta, lung, skeletal muscle, pancreas, spleen, thymus,
prostate, testis, ovary and leukocytes (Fig. 6A).
In normal human colon tissues, TRIM15 was highly expressed in the
differentiated epithelial cells located in the upper portion of human
colon crypts. Notably, TRIM15 staining was predominant in the surface
epithelium as compared to the lower regions of the crypts (Fig. 6B).
Consistent with the TRIM15 protein expression pattern in the colon tis-
sue sections, TRIM15 mRNA was also observed in several colon epithe-
lial cell lines, HCT116, HT-29, and LOVO cells, but not in CCD18Co, a
colon ﬁbroblast cell line (Fig. 6C,D). Taken together, these results sug-
gest that TRIM15 expression is tightly regulated in a tissue-speciﬁc
manner, and expression of TRIM15 may associate with the epithelial
function of the colon mucosa.
3.6. TRIM15 as a negative regulator of cell motility in colon epithelial cells
Next, we examined whether the expression of TRIM15 affected the
motility of the colon epithelial cells. HCT116 and HT-29 cells that con-
taining low levels of TRIM15 mRNA were infected with a retrovirus
that encoding FLAG-tagged TRIM15 (Fig. 7A). As expected, the overex-
pression of TRIM15 signiﬁcantly inhibited the migration of HCT116
and HT-29 cells (Fig. 7B). To conﬁrm the negative role of TRIM15 in
colon epithelial cell migration, we assessed the impact of suppressing
TRIM15 expression by siRNA treatment on the migration of LOVO
colon cancer cells, which demonstrated a higher basal expression of
TRIM15 than the other cell lines tested (Fig. 7C). We found that the
siRNA-mediated inhibition of TRIM15 expression enhanced the migra-
tion of the LOVO cells (Fig. 7D). Taken together, our data suggest that
TRIM15 negatively regulates cell migration of colon epithelial cells.
3.7. TRIM15 expression is downregulated in colon adenocarcinoma and the
level of TRIM15 expression affects tumor growth
To examine whether TRIM15 expression is altered in colon ade-
nocarcinomas, which acquire higher cellular motility, we performed
RT-PCR on cDNAs obtained from 5 patients with colorectal tumors
(Fig. 8A,B). Notably, the expression of TRIM15 mRNA was suppressed
in most of colon cancer patient samples. Using immunohistochemistry,
we found that the strong TRIM15 signals observed in the normal colon
epithelium were dramatically reduced in the colon adenocarcinoma
samples (Fig. 8C). The reduced expression of TRIM15 in colon adenocar-
cinoma suggested that TRIM15might normally prevent cancer progres-
sion. To investigate this hypothesis, we assessed the effect of stable
TRIM15 expression in HCT116 and HT-29 cells on colonogenicity. The
HCT116 andHT-29 cells that expressed the vector alone formed numer-
ous colonies in soft agar; however, the TRIM15-expressing cells had
signiﬁcantly fewer colonies in soft agar (Fig. 8D). Next, we examined
the effect of TRIM15 on tumor growth in vivo. To this end, we inoculated
nude mice subcutaneously with HT-29 cells stably expressing TRIM15
or control HT-29 cells. Although tumors formed in both groups, the
growth of tumors derived from cells expressing TRIM15was signiﬁcant-
ly suppressed (Fig. 8E). Together, these results support the possibility
that downregulation of TRIM15 might promote the progression of
colon adenocarcinoma by increasing cellular migration and growth of
colon cancer cells.
4. Discussion
Cell-ECM adhesion is a primary site of force transmission between
the cell and the ECM and is mostly mediated by integrins in the cell
Fig. 4. TRIM15 interacts with known regulators of actin dynamics. A) Identiﬁcation of protein-protein interactions between TRIM15 and integrin adhesomes using a ﬂuorescence protein
complementation assay. The percentage of cells containing YFP ﬂuorescence resulting from protein-protein interaction was measured by ﬂow cytometry. Cells stably expressing TRIM-
YFPn and YFPc were used as control. B) A biochemical analysis of protein-protein interactions of TRIM15. 293T cells were co-transfected with plasmids encoding GST or GST-TRIM15
with either FLAG-tagged CORO1B, CTTN, FBLIM1, or VASP. GST or GST-TRIM15 was precipitated using glutathione agarose beads. Protein interaction with TRIM15 was determined by
immunoblotting with the anti-FLAG antibody. Input indicates 1% of the cell lysates used for the GST pull down assay. C) Signaling network associated with TRIM15 interacting proteins.
The functions of CORO1B, CTTN, VASP, and FBLIM1 are closely related with actin remodeling and cell movement. Interactions between TRIM15 and identiﬁed proteins were analyzed
and drawn by using Ingenuity Pathway Analysis software.
416 O.-H. Lee et al. / Biochimica et Biophysica Acta 1853 (2015) 409–421membrane. Integrin ligation to the ECM triggers a conformational
change of integrins, which promotes their linkage to the actin cytoskel-
eton through multi-protein complexes [18,19]. The network of proteininteractions between themulti-protein complexes comprises structures
termed focal contacts or focal adhesions. The molecular composition
of focal adhesions dictates cellular behaviors such as migration. Our
Fig. 5. TRIM15 interacts with CTTN and inhibits cell migration bymodiﬁcation of CTTN phosphorylation. A) Co-immunoprecipitation of TRIM15with CTTN. Whole cell lysates from U2OS
cells stably expressing FLAG-TRIM15 were incubated with anti-FLAG antibody. FLAG-TRIM15 was precipitated by adding protein A/G agarose bead. Co-immunoprecipitated CTTN and
FLAG-TRIM15 were detected by anti-CTTN and anti-FLAG antibodies, respectively. Cell lysates from U2OS cells transfected with vector were used as control. Input contains 10% of the
cell lysates. B) Co-localization of TRIM15 and CTTN. U2OS cells stably expressing FLAG-TRIM15 were stained with anti-FLAG and anti-CTTN antibodies. The scale bar indicates 2 μm.
C) The effect of TRIM15 on EGF-induced tyrosine phosphorylation of CTTN. Cells stably expressing vector or FLAG-TRIM15 were serum-starved and activated with 50 ng/ml of EGF for
the indicated times. Cell lysates were analyzed by immunoblotting with anti-phospho-CTTN (Tyr 421), anti-CTTN, anti-FLAG, and anti-β-actin antibodies. β-actin was used as an internal
control. D) Knockdown of CTTN by CTTN siRNA. U2OS cells were transfectedwith either control (50 nM) or CTTN (25 and 50nM) siRNA. siCtrl and siCTTN indicate control siRNA and CTTN
siRNA, respectively. Knockdown of CTTN was determined byWestern blots. β-actin was used as an internal control. E) Effect of CTTN siRNA on TRIM15-inhibited cell motility. U2OS cells
stably transfected with vector or expressing FLAG-TRIM15 were transfected 25 nM of control or CTTN siRNA using Lipofectamine RNAiMax. After 2 days, cells were added to migration
chamber and allowed tomigrate through for 7 h. The cells that passed through themembranewere counted and compared to vector-expressing cells treatedwith control siRNA (normal-
ized to 100%). The experimentswere performed in triplicate. The bars represent themean± SD from three independent experiments. *p b 0.05 versus the vector control cells treatedwith
siCtrl; #p b 0.05 versus the TRIM15-expressing cells with siCtrl.
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Fig. 6. Expression of TRIM15. A) The distribution of TRIM15 expression in human tissues. The expression of TRIM15mRNAwas analyzed in normal human tissues using real-time PCR. The
result was obtained from the representative experiment which was performed in triplicate. B) The TRIM15 expression pattern in normal human colon epithelium. Normal colon mucosa
biopsies of thehuman large intestinewere stainedwith an anti-TRIM15 antibody. TRIM15was expressed in the differentiated colon epithelial cells (i)more than in themigrating epithelial
cells (ii). The scale bar indicates 20 μm. C) TRIM15 mRNA expression in colon ﬁbroblast (CCD18Co) and epithelial cell lines (HCT116, HT-29, and LOVO). SH-SY5Y and U2OS cells are
neuroblastoma and osteosarcoma cell lines, respectively. The expression of TRIM15 mRNA was analyzed using semi-quantitative RT-PCR (upper panel) and quantitative real-time PCR
(bottom panel). The result was obtained from the representative experiment which was performed in triplicate. β-actin was used as an internal control and 18S rRNA was used for
normalization of TRIM15 mRNA levels.
418 O.-H. Lee et al. / Biochimica et Biophysica Acta 1853 (2015) 409–421microscopic analysis indicated that TRIM15 was prominently enriched
in focal contacts or focal adhesions. Since TRIM15 contains a coiled-
coil domain, which mediates both homo- and hetero-dimeric interac-
tions as well as higher-order multimer interactions [1,20], TRIM15
may homo-multimerize into high molecular weight complexes and
play a role as a scaffolding protein to recruit speciﬁc signaling proteins
to cell-ECM adhesion sites to regulate cell motility. TRIM family proteins
containing PRY/SPRY domain acquire antibody-like architectures which
are able to bind targets ranging from small molecules and peptide epi-
topes provided by proteins [21]. The PRY/SPRY domain of TRIM15may confer target-binding speciﬁcity to TRIM15. Disruption of the
PRY/SPRY regions was associated with diffuse localization of TRIM15
in cells and the loss of inhibition of TRIM15 in cell migration, suggesting
that speciﬁc protein interactions through the PRY/SPRY domain was
essential for the function of TRIM15.
Our results show that the RING domain in TRIM15 is not necessary
for either TRIM15 localization to focal adhesion or the inhibitory effect
on cell migration. RING domains are known to play a critical role in me-
diating the transfer of ubiquitin to speciﬁc substrates. Therefore, this
domain is a distinct feature of many E3 ubiquitin ligases. In fact, many
Fig. 7. TRIM15 inhibits migration of colon cancer cells. A) TRIM15 levels in HCT116 and HT-29 cells stably expressing vector alone or FLAG-TRIM15. Total RNA from cells was analyzed by
real-time RT-PCR and normalized to the 18S rRNA levels. The result was obtained from the representative experiment which was performed in triplicate. B) Overexpression of TRIM15
inhibits the migration of colon cancer cells. HCT116 and HT-29 cells stably expressing the vector or FLAG-TRIM15 were seeded onto a transwell system. The TRIM15-expressing cells
that passed through the membrane were counted and compared with vector-expressing cells (normalized to 100%). The experiments were performed in triplicate. The bars represent
the mean ± SD from three independent experiments. *p b 0.05 versus the vector control cells; **p b 0.001 versus the vector control cells. C) Real time RT-PCR analysis of the suppression
of TRIM15 expression by siRNA treatment. LOVO cells were transfected with 50 nM of either control or one of two different TRIM15 siRNAs using Lipofectamine RNAiMax. siCtrl and
siTRIM15 indicate control and TRIM15 siRNA, respectively. The result was obtained from the representative experiment which was performed in triplicate. D) The suppression of
TRIM15 expression by siRNA treatment enhances cell migration. LOVO cells transfected with the control or TRIM15 siRNA were added to the migration chamber. After 2 days, the cells
that migrated were photographed, and the results represent the percentage of migration compared to the migration of the mock-treated cells (normalized to 100%). The experiments
were performed in triplicate. The bars represent the mean ± SD from three independent experiments. *p b 0.05 versus the mock-treated cells; **p b 0.005 versus the mock-treated cells.
419O.-H. Lee et al. / Biochimica et Biophysica Acta 1853 (2015) 409–421other types of TRIM family proteins have been shown to interact with
ubiquitin-conjugating E2 enzymes. Conversely, TRIM15 was not shown
to interact with UBE2 enzymes [22], supporting the possibility that
theRING domain of TRIM15 is not associatedwith E3 ubiquitin ligase ac-
tivity. Furthermore, our data indicated that the RING domain of TRIM15
is not responsible for TRIM15-mediated inhibition of cell migration.
Our small-scale screen for TRIM15 binding to integrin adhesome
proteins revealed a possible link between TRIM15 and dynamic changes
of the actin cytoskeleton, including assembly and disassembly of
actin ﬁlaments and focal adhesion formation. VASP, FBLIM1, CTTN, and
CORO1Bwere the representative TRIM15-bindingproteins that regulate
actin dynamics. TRIM15was also interactedwith signaling adaptors and
kinases involved in post-translational modiﬁcation. Although we did
not provide a detailed mechanism by which these interacting proteins
mediate TRIM15 functions to inhibit cell migration, it is likely that
TRIM15 serves as a scaffolding protein under integrin to recruit several
signaling molecules and effectors that affect cellular motility.
Our study indicates that CTTN is oneof regulators affected by TRIM15
expression.We did not observe TRIM15 effect on VASP phosphorylation(data not shown). Basal level of tyrosine phosphorylation of CTTN was
higher in cells expressing TRIM15, suggesting that CTTN phosphoryla-
tion was altered by TRIM15. Moreover, EGF did not induce CTTN tyro-
sine phosphorylation in TRIM15-expressing cells. Phosphorylation
status of CTTN is believed to be critical for actin dynamics [23]. Serine
phosphorylation (S405 and S418) activates CTTN binding to N-WASP
for actin polymerization, whereas tyrosine phosphorylation (Y421,
Y466, and Y482) inhibits N-WASP-mediated actin polymerization [15].
This reciprocal serine/tyrosine phosphorylation of CTTNmight ultimate-
ly control cell migration through tight regulation of actin remodeling. In
addition, CTTN is known to a negative or positive regulator of cell migra-
tion depending on its tyrosine phosphorylation [17]. Knockdown of
CTTN impairs cell motility in gastric cancer cell lines with lower level
of phosphorylated CTTN, whereas it increases cell migration in gastric
cancer cell lines with hyperphosphorylated CTTN. Differential functions
of CTTN are known to be resulted from activation of p130Cas pathway.
Knockdown of hyperphosphorylated CTTN enhances p130Cas activation
increasing cell motility. Therefore, distorted regulation of CTTN phos-
phorylation by TRIM15 may be involved in inhibition of cell migration.
Fig. 8. TRIM15 expression was downregulated in colon adenocarcinoma and TRIM15 suppressed in vitro and in vivo tumor growth. A) A representative image of RT-PCR analysis using
TRIM15-speciﬁc primers. The TRIM15 mRNA expression levels were analyzed in matched normal colon tissues (N) and colon cancer tissues (T) from 2 colon cancer patients. β-actin
was used as an internal control. B) Quantitative real-time PCR analysis of the TRIM15 mRNA levels in ﬁve paired human colon cancer and adjacent normal colon tissues. TRIM15
mRNA level was normalized to the 18S rRNA (mean ± SD). *p b 0.01 versus the normal colon tissues. C) Representative immunohistochemical staining of TRIM15 in normal tissue (i),
and two colon cancer tissues (ii and iii). The scale bar indicates 50 μm. D) TRIM15 inhibited the anchorage-independent growth of colon cancer cells. A soft agar assay was performed
using HCT116 and HT-29 cells stably expressing the vector alone or FLAG-TRIM15. The colonies observed in 6-well triplicates were counted to determine themean± SD. *p b 0.05 versus
the vector control cells; **p b 0.001 versus the vector control cells. E) Inhibitory effect of TRIM15 on tumor growth in vivo. HT-29 cells stably expressing vector (n = 9) or FLAG-TRIM15
(n = 9) were inoculated subcutaneously into nude mice. Tumor volumes (mean ± SD) were obtained from 9 mice and plotted. *p b 0.05 versus the vector control.
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421O.-H. Lee et al. / Biochimica et Biophysica Acta 1853 (2015) 409–421The expression of TRIM15 was highly tissue-selective and was
enriched in the colon. Colon epithelial cells undergo a spatially and tem-
porally regulatedmaturation program, as theymigrate along the colonic
crypt axis toward the luminal surface [24]. Our ﬁnding that TRIM15
is highly expressed in the upper-epithelial region of colon crypts and
the surface epithelium suggests that TRIM15 plays an important role
in maturation programming of intestinal epithelial cells. To induce
colon cell differentiation, the genetic reprogramming that regulates
cell motility is essential. Several cell structure and adhesion proteins,
as well as the genes associated with a reduced rate of cell migration,
are up-regulated in differentiated colon epithelial cells [25,26]. Our ob-
servation that TRIM15 expression suppresses cell motility indicates a
possible function of TRIM15 in colon epithelial cell maturation.
Deregulated expression of proteins that control cell-ECM adhesion
and cell migration plays a key role in cancer development. For example,
nischarin has been identiﬁed as an interacting protein with the integrin
α5 subunit. Nischarin reducesα5β1-dependent cellmigration in several
cell types [27]. The loss of nischarin expression is strongly associated
with breast cancer progression [28]. β-parvin, an adaptor protein that
binds to the integrin-linked kinase, is also downregulated in breast can-
cer. Ectopic expression of β-parvin in breast cancer cells suppresses
anchorage-independent cell growth and tumor cell invasion [11].
Likewise, RT-PCR analysis and immunohistochemical analysis of colon
cancer tissues revealed that TRIM15 expression was signiﬁcantly re-
duced in colon adenocarcinoma samples. Conversely, overexpression
of TRIM15 inhibited cell motility, as well as both in vitro and in vivo
growth of colon cancer cells. These observations suggest that TRIM15
may function as a tumor suppressor by modulating the focal adhesion
complex-dependent signaling pathway.
Taken together, our data indicate that a potential association exists
between TRIM15, a component of focal adhesions, and the differentia-
tion of epithelial cells or anti-tumorigenic activity. Although we have
identiﬁed possible roles for TRIM15 in focal adhesion sites regulating
cell migration, the deﬁnitive mechanism by which TRIM15 localizes
to focal adhesions and inhibits cellular migration remains unclear. To
answer this question, further studies of the effects of TRIM15 on the
interacting proteins that we identiﬁed in this work will be important.
The epigenetic modiﬁcation controlling both the transcriptional activa-
tion of TRIM15 in colon epithelial cells undergoing differentiation and
the transcriptional suppression of TRIM15 in cancer will be of great in-
terest for future studies. A greater understanding of this processwill un-
doubtedly provide important information for understanding intestinal
homeostasis and tumorigenesis.
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